DUBLIN–(BUSINESS WIRE)–The “Container Closure Integrity Testing Services Market by Type of Container Closure Systems, Type of Container Materials Tested, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering.
This report features an extensive study of the current landscape and the likely future potential of container closure integrity testing service providers, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.
Packaging is considered a critical aspect of pharmaceutical manufacturing. It is, therefore, imperative for drug manufacturers to ensure that formulations enclosed in primary containers are safe for consumption / administration. Despite being well established, there are several concerns associated with the drug packaging process, such as the risk of contamination, filling errors (inaccurate dose dispensation), complex packaging systems, integrity related concerns (pores, cracks and scratches) of container closure systems (such as vials, syringes, cartridges, IV bags, ampoules), and labelling-related issues. In fact, experts believe that around 80% of product recalls may be attributed to packaging-related concerns.
To ensure the safety of consumers, a lot of effort is put to eliminate contamination, filling errors and maintain integrity of packaged formulations. The industry has come up with several innovative techniques and technologies for the evaluation of both primary and secondary packaging components in order to maintain the sterility and stability of drug product. Moreover, regulatory bodies have enforced stringent guidelines to evaluate the integrity of container closure systems. As a result, container closure integrity testing has become a critical part of the overall manufacturing process. The techniques used for this purpose ensure precision and accuracy in leak detection, rapid results, non-destructive testing, affordable, reliable and easy integration in the manufacturing process.
Despite the benefits of container closure integrity testing methods, there is no one-size -fits-all solution to evaluate all the types of primary packaging. Additionally, the pharmaceutical and biopharmaceutical companies face various challenges in installing container closure integrity testing equipment due to limited expertise and infrastructure. Owing to these challenges, the drug manufacturers rely on container closure integrity testing service providers, which have well-equipped infrastructure and novel technology platforms, along with the required expertise. Moreover, outsourcing of container closure integrity testing assists the innovators to serve the clients in a timely and regulation-compliant manner. With the anticipated rise in the drug product market, the demand for packaging services is likely to increase in the future; this, in turn, will likely result in rise in demand for integrity testing services. Further advancements in testing methods and cost saving potential of such methods (by reducing the product wastage and ensuring the drug and patients safety) are expected to drive steady growth in the overall container closure integrity testing services market in the foreseen future.
Key Questions Answered
- Who are the leading players offering container closure integrity testing service?
- What is the relative competitiveness of container closure integrity testing service providers?
- In which regions are majority of the container closure integrity testing facilities located?
- Which type of equipment have the competitive edge over the other container closure integrity testing equipment?
- What is the current and future demand for container closure integrity testing services?
- How is the current and future opportunity likely to be distributed across key market segments?
Companies Mentioned
- Alcami
- Alfa Chemistry
- ALPS Inspection
- AptarGroup
- ARL Bio Pharma
- Aseptic Technologies
- AST
- Astellas Pharma
- Advanced Test Concepts (Acquired by Pfeiffer Vacuum)
- Berkshire Sterile Manufacturing (BSM)
- Bonfiglioli Engineering
- Bosch Packaging Technology (now Syntegon)
- Confarma (a subsidiary of Solvias)
- Coriolis Pharma
- Corning
- CS Analytical
- Curia (Formerly known as AMRI)
- Dara Pharmaceutical Packaging
- Datwyler
- DDL Diagnostic Laboratory
- Eagle Analytical
- Eurofins Scientific
- Fedegari
- Fresenius Kabi
- Gateway Analytical
- Gerresheimer
- Gibraltar Laboratories
- Groupe IDEA TESTS (Acquired by SGS)
- IMA
- Infinity Laboratories
- Integrity Bio (Acquired by Curia)
- Jubilant HollisterStier
- Labor LS
- Labthink
- LakePharma (Acquired by Curia)
- LexaMed
- Lighthouse Instruments
- Lonza
- Medical Engineering Technologies
- Metair Health & Hygiene Testing Lab (Acquired by SGS)
- Mithra CDMO
- Nelson Labs
- NEUMA
- Nikka Densok
- Nitto Avecia Pharma Services (Formerly known as Irvine Pharmaceutical Services and Avrio Biopharmaceuticals)
- NUVISAN
- OFI
- Pace Analytical Life Sciences
- Pacific Biolabs
- Pfeiffer Vacuum
- PPD
- Packaging Technologies & Inspection (PTI)
- Sepha
- SGS
- Signify
- Smithers
- STEMart
- Steriline
- Stevanato Group
- Syntegon
- Tepnel Pharma Services
- Vanrx Pharmasystems (Acquired by Cytiva)
- VITAS AS
- West Pharmaceutical Services
- Wickham Laboratories
- WILCO
- WuXi Advanced Therapies
- ZebraSci
For more information about this report visit https://www.researchandmarkets.com/r/arhh3c
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900